Skip to content
Atea Pharmaceuticals Inc icon

Atea Pharmaceuticals Inc

AVIRStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$5.63

Today

+3.9%

YTD

+51.3%

About

Atea Pharmaceuticals Inc is a biopharmaceutical company committed to discovering, developing and commercialising innovative therapies to address severe viral diseases, with operations spanning the globe. Operating in the biotechnology sector, Atea Pharmaceuticals Inc caters its services largely to the healthcare industry. Known for its innovative scientific research methodologies, the company works on therapeutic advancements in treating severe viral infections. It is also known for its vital research into the COVID-19 and HCV viruses. Leverage the opportunity to explore AVIR's share prices and other stocks on eToro.

Price chart
Closing price history for AVIR (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.35
P/S (TTM)0.00
P/B (TTM)1.71
Market cap$399.34M
Cap tierSmall-cap
Industry avg P/E-43.27

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-52.58%
ROA-47.95%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$2.12
Free cash flow$-147.86M
Total debt$634,000.00

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.75
Employees55
Next earnings11 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Atea Pharmaceuticals Inc (AVIR) | Dirk Kuyken